(Total Views: 623)
Posted On: 05/07/2019 5:34:08 PM
Post# of 15624
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Hitbodedut10 #15095
This kind of study should show the rate at which the body takes in the MGC-ODT without interference from liver, or stomach acids. It'll also show how fast the dosages disperse. I'm thinking our researchers could begin to address dosage amounts and whether to coat some dosages to delay absorbtion so that a longer, and more controlled delivery be done in the future. Also this study may tell if this type of delivery system causes a "sensory" overload which could trigger other physiological reactions (good and bad). We are trying a new approach to administering MGC-ODT and we are starting by doing these fundamental, yet broad and recognized testing procedures, that are accepted by the medical research world(pharmacokenetics). If this delivery system shows merit, a potential patent on the system could be yet another revenue stream for the company. Stockfan is correct by surmising that OWCP has significant opportunities should this study identify superiority over Sativex.
Thanks Hitbodedut 10 for posting this.
Thanks Hitbodedut 10 for posting this.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)